# Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

> **NCT00236938** · PHASE3 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 121 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Venofer and stable erythropoietin (EPO) regimen
- **DRUG:** stable erythropoietin (EPO) regimen

## Key facts

- **NCT ID:** NCT00236938
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2004-09
- **Final completion:** 2004-10
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2021-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236938, "Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00236938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*